A detailed history of Criterion Capital Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Criterion Capital Advisors, LLC holds 1,504 shares of PFE stock, worth $38,758. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,504
Previous 1,504 -0.0%
Holding current value
$38,758
Previous $42.1 Million -0.0%
% of portfolio
0.03%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$25.26 - $29.6 $656 - $769
-26 Reduced 1.7%
1,504 $42.1 Million
Q1 2024

Apr 17, 2024

SELL
$25.89 - $29.73 $55,301 - $63,503
-2,136 Reduced 58.27%
1,530 $42.5 Million
Q4 2023

Jan 31, 2024

BUY
$26.13 - $33.94 $95,792 - $124,424
3,666 New
3,666 $106 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Criterion Capital Advisors, LLC Portfolio

Follow Criterion Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Criterion Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Criterion Capital Advisors, LLC with notifications on news.